Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Despite ...
(WJET/WFXP)– Bleeding disorders can turn the most mild of episodes a serious situation and to shed light on the conditions that affect roughly 30,000 Americans, the Bicentennial Tower will be lighting ...
Alphanate1 250 IU, 500 IU, 1000 IU, 1500 IU, 2000 IU lyophilized pwd for IV inj after reconstitution Adults: Pre-op: 60 VWF:RCo IU/kg, then 40–60 VWF:RCo IU/kg every 8–12hrs if needed; may reduce dose ...
Findings showed that routine prophylaxis with wilate resulted in an 84% reduction in mean total ABRs compared with on-demand treatment. The Food and Drug Administration (FDA) has expanded the approval ...
Columnist Jennifer Lynne recently attended the CHES Foundation's One Drop consortium, a powerful space for those with rare bleeding disorders.
A handful of pharmas and celebrities are joining forces with the National Bleeding Disorders Foundation (NBDF) for a ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced interim clinical data from ...
insights from industryDr. Carmen Escuriola-Ettingshausen MDHämophilie-Zentrum Rhein Main An interview with Dr. Carmen Escuriola-Ettingshausen MD, Hämophilie-Zentrum Rhein Main, Mörfelden-Walldorf, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced that the U.S. Food and Drug ...
Odisha's health department has introduced two advanced medicines for haemophilia and Von Willebrand disease patients, marking a first for the state. These extended half-life Factor VIII and Von ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results